| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Tate Michael Truett | Chief Financial Officer | C/O ASTERA LABS, INC., 2345 NORTH FIRST STREET, SAN JOSE | /s/ Philip Mazzara, Attorney-in-Fact | 20 Aug 2025 | 0001399546 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALAB | Common Stock | Sale | $7,324,352 | -43,184 | -7% | $169.61 | 575,812 | 07 Aug 2025 | By Tate Trust | F1, F2 |
| transaction | ALAB | Common Stock | Sale | $1,286,064 | -7,550 | -1.3% | $170.34 | 568,262 | 07 Aug 2025 | By Tate Trust | F2, F3 |
| transaction | ALAB | Common Stock | Sale | $2,596,345 | -15,141 | -2.7% | $171.48 | 553,121 | 07 Aug 2025 | By Tate Trust | F2, F4 |
| transaction | ALAB | Common Stock | Sale | $5,931,724 | -34,125 | -6.2% | $173.82 | 518,996 | 07 Aug 2025 | By Tate Trust | F2, F5 |
| transaction | ALAB | Common Stock | Gift | $0 | -7,500 | -1.4% | $0.000000 | 511,496 | 07 Aug 2025 | By Tate Trust | F2, F6 |
| transaction | ALAB | Common Stock | Gift | $0 | -10,000 | -2% | $0.000000 | 501,496 | 08 Aug 2025 | By Tate Trust | F2, F7 |
| holding | ALAB | Common Stock | 278,373 | 07 Aug 2025 | Direct |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $169.0500 to $169.9900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the "Tate Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| F3 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $170.0500 to $170.8600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $171.0800 to $171.8500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $173.5950 to $174.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F6 | Represents a bona fide gift of shares to a non-affiliated entity. |
| F7 | Represents a bona fide gift of shares to a non-affiliated person. |
This Form 4/A (this "Amendment") amends and restates in its entirety the original Form 4 filed with the U.S. Securities and Exchange Commission on August 11, 2025 (the "Original Form") to remove the transaction relating to the acquisition of Astera Labs, Inc. common stock ("Common Stock") by GlobalStar Donor Advised Fund ("DAF"), of which the Reporting Person was inadvertently reported due to administrative error as being a trustee. In fact, the Reporting Person has no pecuniary interest in GlobalStar DAF; as such, the 7,500 shares were gifted to and acquired by a non-affiliated entity, as reported in this Amendment.